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Natural product biosynthetic pathways generate molecules of
enormous structural complexity and exquisitely tuned biological
activities. Studies of natural products have led to the discovery of
many pharmaceutical agents, particularly antibiotics. Attempts to
harness the catalytic prowess of biosynthetic enzyme systems, for
both compound discovery and engineering, have been limited by
a poor understanding of the evolution of the underlying gene
clusters. We developed an approach to study the evolution of biosynthetic genes on a cluster-wide scale, integrating pairwise gene
coevolution information with large-scale phylogenetic analysis. We
used this method to infer the evolution of type II polyketide gene
clusters, tracing the path of evolution from the single ancestor to
those gene clusters surviving today. We identified 10 key gene types
in these clusters, most of which were swapped in from existing
cellular processes and subsequently specialized. The ancestral type
II polyketide gene cluster likely comprised a core set of five genes,
a roster that expanded and contracted throughout evolution. A key
C24 ancestor diversified into major classes of longer and shorter
chain length systems, from which a C20 ancestor gave rise to the
majority of characterized type II polyketide antibiotics. Our findings
reveal that (i) type II polyketide structure is predictable from its gene
roster, (ii) only certain gene combinations are compatible, and
(iii) gene swaps were likely a key to evolution of chemical diversity. The lessons learned about how natural selection drives
polyketide chemical innovation can be applied to the rational
design and guided discovery of chemicals with desired structures
and properties.
evolution

| polyketide | natural products | gene cluster

chain. Reactive beta-keto chains are converted into structurally
diverse molecules by the action of tailoring enzymes, including
cyclases and reductases, giving rise to the final branching, oxidation state, and cyclization pattern of the polyaromatic product.
The remarkable chemical diversity observed in this class of
molecules is thought to originate from variations in chain length
and tailoring reactions. Previous phylogenetic studies have
revealed the role of the CLF in controlling the chain length of
type II polyketides (8–15), but the evolution of the KS-CLF
within the context of the entire protein assembly is not well
understood.
Our analyses trace the evolution of type II PKS gene clusters,
from the initial divergence of an ancestral KS into the homologous KS-CLF pair, and the gain of several key classes of accessory enzymes. We identified 544 putative type II PKSs in public
genome databases, ∼15% of which encode a product that has
been structurally characterized. Our studies revealed that the
ancient pairing of the KS and CLF coincided with the gain of two
accessory genes responsible for ring cyclization, an evolutionary
shift that likely resulted in the introduction of the characteristic
polyaromatic structure of type II polyketides. Subsequent gene
swaps of accessory enzymes were highly coordinated with mutations to the KS-CLF, thereby enabling PKSs to diversify the
chain length, oxidation state, and overall shape of their molecular products. These findings provide an unprecedented glimpse
into the mechanisms by which evolution has led to the chemical
diversity of natural products. The application of these methods
to other gene collectives could unveil additional modes of
chemical diversity generation in nature.

M

icroorganisms produce structurally diverse secondary metabolites, many of which have been successfully repurposed by
mankind as pharmaceutical agents. These molecules are manufactured by multienzyme assemblies, many of which are encoded
by biosynthetic gene clusters. Elucidating the history of how gene
clusters evolved to produce a powerhouse of structurally diverse
and biologically active molecules could reveal how synthases can
be engineered to produce new therapeutic agents. Phylogenetic
analyses have revealed evolutionary histories of individual biosynthetic genes, but the mechanisms of evolution of entire gene
clusters are not well understood (1–4).
Here, we present an approach to study gene cluster evolution
on a cluster-wide scale, and we apply it to type II polyketide gene
clusters. In their native bacterial hosts, type II polyketides are
thought to confer a selective advantage by serving important
roles in chemical defense, signaling, and virulence (5). This class
is rich in pharmacologically relevant compounds, including potent antibiotics (e.g., tetracycline) and anticancer agents (e.g.,
doxorubicin) (5, 6). The historical success of type II polyketides
in the clinic, coupled with the need for new antibiotics, has
spurred great interest in identifying and engineering new compounds in this class (7). Type II polyketide gene clusters encode
discrete and dissociable polyketide synthase (PKS) enzyme assemblies. The core proteins of type II PKS gene clusters are a
ketosynthase (KS)-alpha subunit and a KS-beta subunit, also
known as a chain length factor (CLF), which collaborate with the
acyl carrier protein (ACP) to construct a nascent polyketide
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Significance
Type II polyketide natural products are powerful antimicrobial
agents that are biosynthesized within bacteria by enzymeencoding clusters of genes. We present a method to elucidate
the evolution of these gene clusters as a whole, illuminating
how natural selection has led to the chemical diversity of type
II polyketides. Our approach can be applied to understand how
other natural product gene clusters evolve. This understanding
may aid efforts to access novel natural products and to design
rational enzyme assemblies that produce chemicals of desired
structures and activities.
Author contributions: M.E.H., G.A.V., E.E.B., and L.K.C. designed research; M.E.H., G.A.V.,
E.E.B., and L.K.C. performed research; M.E.H., G.A.V., E.E.B., and L.K.C. contributed new
reagents/analytic tools; M.E.H., G.A.V., E.E.B., and L.K.C. analyzed data; and M.E.H.,
G.A.V., and L.K.C. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Freely available online through the PNAS open access option.
Data deposition: Data are available for download and visualization at sequence.stanford.
edu/TypeIIPKS/.
1

To whom correspondence may be addressed. Email: maureenh@stanford.edu or lcharkou@
haverford.edu.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1511688112/-/DCSupplemental.

www.pnas.org/cgi/doi/10.1073/pnas.1511688112

Resistomycin
and orphans

1
2
3

C24
(Spore
pigments)

Common ancestor
of characterized
type II PKS
KS-CLFs

C24
(Frankiamycin)

4
C24-C26
5

= Characterized
gene cluster

C28-C30
6

C21
7

C18
C16

Actinobacteria
Firmicutes

8

Cyanobacteria
Proteobacteria
Planctomycetes, Spirochetes

C20

Other bacteria,
Environmental samples

0.5

Fig. 1. Phylogeny of CLF protein sequences from 544 putative type II PKS gene
clusters. Red numbers represent key ancestors. Leaf colors represent phylum of
origin. Gene clusters clade by polyketide chain length (noted on the right).

Results and Discussion
Evolution of the Core KS and CLF Proteins. The KS, CLF, and ACP
proteins form the minimal assembly required to build a nascent
polyketide chain (SI Appendix, Fig. S1). Ridley et al. (8) proposed that the core KS and CLF genes of type II PKS gene
clusters arose from an ancient KS duplication. Using a large set
of recent bacterial genomic sequence data, we performed largescale phylogenetic analysis of many newly sequenced homologs
of the KS and CLF genes (SI Appendix, Fig. S2), resulting in two
new insights into the nature and timing of this duplication in the
context of bacterial evolution. First, type II PKS KSs appear
more similar to primary metabolic FabF KS homologs from the
fatty acid (FAS) pathway than to the KS of several secondary
metabolic type II PKS relatives, such as aurachin and kedarcidin
(1, 3, 4, 16–18). These other secondary metabolic gene clusters
harbor tandem KSs that appear superficially similar to the tandem KSs of type II PKS gene clusters (SI Appendix, Fig. S2 A and
B). However, our detailed phylogeny reveals that the tandem KS
pair of these other secondary metabolic gene clusters arose from
a separate duplication event, distinct from the duplication
leading to canonical type II PKS KS-CLF genes. Second, despite
type II PKS clusters having been identified exclusively in Actinobacteria, and despite their high similarity to FabF homologs
(SI Appendix, Fig. S2 A and B), the KS and CLF proteins do not
clade with actinobacterial FabF (SI Appendix, Fig. S2C). The
divergence of the type II KS from the FabF KSs predates major
bacterial speciation events, as visible by the FabF sequences
grouping by phylum of origin. This finding suggests that type II KS
and CLF genes did not evolve from an ancestral actinobacterial
FabF, but rather diverged from the FabF common ancestor well
before the actinobacterial phylum had formed.
To study the evolution of all type II PKS gene clusters sequenced to
date, we searched public genomic sequence data in the GenBank
(February 19, 2015) for KS-CLF gene homologs present in tandem
Hillenmeyer et al.

(SI Appendix, Methods and Figs. S3–S5). We defined a redundancy
threshold of 87% CLF sequence identity (at which gene clusters tend
to encode identical rather than unique small molecules; SI Appendix,
Methods). Our search identified 544 nonredundant putative type II
PKS gene clusters, exclusively in bacteria (Fig. 1). These gene clusters included 78 (all actinobacterial) whose secondary metabolite
products have been structurally characterized. We identified many
orphan gene clusters in nonactinobacterial species; these gene clusters are very anciently diverged from actinobacterial homologs (not
likely recently horizontally transferred), with sparse coverage of sequence space (Fig. 1 and SI Appendix, Fig. S2). The nonactinobacterial
gene clusters are attractive targets for bioprospecting, because
their origin in phyla such as Firmicutes and Proteobacteria
could allow for expression in tractable nonactinobacterial
heterologous hosts.
Phylogenetic analysis of characterized genes corroborated
previous findings that CLF proteins group by chain length, in
both the large dataset of 544 putative type II PKS clusters (Fig.
1) and the smaller set of 78 characterized gene clusters (Fig. 2).
We computationally tested the long-standing hypothesis that the
volume of the KS-CLF amphipathic cavity, which houses the
growing polyketide chain during biosynthesis, is a main determinant of polyketide chain length (5, 8–15). Using the solved
actinorhodin KS-CLF structure as a template for in silico mutagenesis, we calculated the predicted volume of the KS-CLF
cavity for five PKS clades (Fig. 2): C16–C18, C20, C24, C26, and
C28–C30 (SI Appendix, Fig. S6 and Table S1). Larger KS-CLF
cavities are correlated with longer polyketides (SI Appendix,
Table S2). Interestingly, the predicted change in cavity volume
is more pronounced between C16–C24 (347 A3) than C24–C30
(81 A3). This observation could reflect the limitation of relying
on homology models built from a single, short-chain template
structure, or it may suggest that the cavity size of the KS-CLFs
encoding the largest polyketides does not expand enough to
accommodate the entire nascent polyketide chain. It is possible
that in the case of the longest polyketides (C28–C30), auxiliary
enzyme(s) create an expanded solvent-excluded cage, which serves
to protect reactive polyketide intermediates (5, 6, 12). Our clusterwide analysis reveals that CLF mutations are correlated with
changes to the gene roster (discussed below).
Evolution of Type II PKS Accessory Enzymes. The origin and diversification of type II PKS enzymes outside of the KS and CLF
are not well understood. To study cluster-wide evolution, we first
identified classes of accessory genes frequently clustered within
30 kb of the KS-CLF gene pair (Fig. 2, Table 1, and SI Appendix,
Fig. S4). We developed a method to detect gene swap events,
building upon existing approaches (19, 20) to quantify gene pair
coevolution by comparing protein similarity scores between pairs
of homologs. Correlated similarity scores suggest that gene types
coevolved (Fig. 3 A and B). Our results confirmed that the core
KS and CLF coevolved with little to no gene swaps: when two
KSs from different genomes have high similarity, the neighboring
CLFs also have high similarity, and when the KSs have low similarity, the neighboring CLFs also have low similarity (Fig. 3C and
SI Appendix, Fig. S7A). We applied this framework to detect
coevolution of tailoring genes with the core KS, and extended it
to detect discrete homologous gene swap events as off-diagonal
groups (Fig. 3B).
Polyketide backbone. The nascent polyketide chain is constructed
through the collaboration of the KS-CLF with the ACP (SI
Appendix, Fig. S1). All characterized gene clusters for which
there is sufficient coverage (30 kb flanking the KS-CLF) contain
an ACP (Table 1). Large-scale phylogenetic analysis of diverse
ACP homologs revealed that type II PKS ACPs form a clade
distinct from primary FAS and other secondary ACPs (SI
Appendix, Fig. S8). The KS and clustered ACP genes share a
correlated evolutionary history, suggesting they coevolved (Fig.
3D and SI Appendix, Fig. S7 B and C). Interestingly, several
anciently diverged orphan clusters (top of Figs. 1 and 2), do not
harbor an ACP homolog, suggesting that this gene was either
PNAS | November 10, 2015 | vol. 112 | no. 45 | 13953
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absent from the initial ancestor or lost from multiple extant
clusters. The ACP-less clusters must use either an alternative
mechanism of biosynthesis or an ACP encoded outside the
gene cluster.
Besides the ACP, other genes involved in backbone biosynthesis include acyltransferase (AT) and priming KS (KSIII).
Most characterized type II systems are primed with acetyl units
and “borrow” these enzymes from the FAS pathway (8–15, 21–
23). Systems using nonacetate starting units rely on secondary
AT and KSIII enzymes (Fig. 2, Table 1, and SI Appendix, Fig. S1)
and produce polyketides with longer alkyl and alkenyl substituents. We found KSIIIs clustered primarily with long-chain (C28–
C30) systems and ATs clustered with C21 systems (Fig. 2), and
both underwent gene swaps (SI Appendix, Fig. S9).
Oxidation state of the polyketide. Ketoreductase (KR) domains have
a profound effect on the final product, because the oxidation state
of the nascent polyketide chain can direct the regiochemistry of
subsequent cyclizations (6). We found that most gene clusters
contain at least one KR gene (Table 1). Previous phylogenetic
analysis suggested there are four main classes of type II PKS KRs,
13954 | www.pnas.org/cgi/doi/10.1073/pnas.1511688112
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Fig. 2. Phylogeny of 78 CLF protein sequences from the reference
set and selected orphan genes.
Accessory genes identified in the
same gene cluster (within 30 kb)
as the CLF are shown at each leaf.
Leaf colors represent phylum of
origin. Node support for the CLF
phylogeny is shown as Bayesian
posterior probabilities.

which correlate with the regiospecificity of the reduction event: C9,
C15, C17, and C19 (24). The four main classes of KRs are distinct
at the sequence level, evolved with their clustered KS (SI Appendix,
Figs. S9 and S10), and underwent clear swapping events (Fig. 3E).
Cyclization of the polyketide. Cyclases function in a chaperone-like
manner to direct regio- and stereoselective intramolecular
cyclization of the polyketide chain (6, 25, 26). We identified four
commonly occurring, nonhomologous categories of cyclases in
type II PKS gene clusters: TcmN-like, OxyN-like, TcmI-like, and
TcmJ-like (Fig. 3 and Table 1). We found no recognizable sequence or structural similarity between the four categories,
suggesting that they evolved from four distinct ancestors. The
striking finding that a TcmN cyclase homolog is present in 94% of
characterized type II PKS gene clusters (Table 1) prompted us to
focus on its role in the origin and evolution of type II PKS gene
clusters. Remarkably, genes encoding TcmN and OxyN cyclase genes
are present in even the most anciently diverged type II PKS clusters,
suggesting that the introduction of these genes into the ancestral gene
cluster coincided in time with the ancestral KS-CLF duplication
(Fig. 2). The TcmN-like cyclase participates in first- and second-ring
Hillenmeyer et al.

KS
CLF
ACP
Acyltransferase
KSIII
C9 KR
C15 KR
C17 KR
C19 KR
TcmN cyclase
TcmI cyclase
TcmJ cyclase
OxyN cyclase

Percentage of reference
set (78 clusters), %

Percentage of 544
putative clusters, %

100
100
97
29
12
55
14
8
18
94
55
28
21

100
100
77
15
7
36
8
3
8
77
46
32
13

cyclizations (27–29), whereas TcmI-, OxyN-, and TcmJ-like cyclases
are thought to direct subsequent ring closures (5, 30). All four of
these categories share an evolutionary history with their clustered KS
(Fig. 3 F–I), and the TcmN and OxyN genes display evidence of
homologous gene swapping (Fig. 3 F and G).
Inferring the Ancestral Type II PKS Gene Cluster. We found that gene
cluster architecture is remarkably predictable based only on CLF
protein sequence, with accessory gene architectures consistent
within each CLF clade (Fig. 2). This finding suggests that CLF
sequence mutations are correlated with the presence or absence
of surrounding genes, and there have been a finite number of
major evolutionary events, each represented by a different CLF
clade. Each clade in the phylogeny represents a discrete evolutionary “solution” developed by the clade’s single ancestor, and
the architecture of each ancestor is generally revealed by the
shared makeup of its descendants. Fig. 4 summarizes the observed
evolution of these key ancestors (represented as red numbers in
Figs. 1, 2, and 4), in terms of both their encoded chain length and
gene cluster architectures (accessory enzymes).
To elucidate the architecture of the ancestral type II PKS gene
cluster existing immediately after the KS-CLF pairing (ancestor
1 in Figs. 1, 2, and 4), we studied the most anciently diverged
clusters that descended directly from this single ancestor (Fig. 4
and SI Appendix, Fig. S11). These gene clusters are orphans
encoding unknown molecules, but their cluster architectures are
available from our analysis and exhibit remarkable conservation
in gene makeup: Nearly all harbor a KS, CLF, TcmN cyclase,
and OxyN cyclase, and many harbor an ACP, suggesting that the
ancestor of all PKS gene clusters (ancestor 1) harbored these five
genes. It is possible that some of these genes were clustered with
the KS before the KS-CLF pairing. To investigate this possibility,
we performed a detailed analysis of the origin of the tandem KSCLF. These two genes are homologous, and previous suggestions
that they arose from a gene duplication implies that this duplication
occurred in a single species, at a single genetic locus (8). However,
an alternative hypothesis, that the ancestral KS diverged by evolution in two different species followed by a later reunion of the two
genes in a single species, cannot be ruled out from the existing
sequence data. We identified a clade of gene clusters comprising a
single KS clustered with an ACP and TcmN homolog, which could
represent either (i) descendants of an ancestral cluster before a
“swapping in” of the CLF or (ii) descendants of an ancestor that
harbored the KS, CLF, ACP, and TcmN but subsequently lost the
CLF. Very few gene clusters have been sequenced that descended
from these key intermediate ancestors, unfortunately obscuring the
order of events in which these five key genes became clustered.
Additional sequencing data will better elucidate these early evolutionary paths.
Hillenmeyer et al.

Functional Consequences of Gene Swaps in Type II PKS Gene Clusters.

Having established the likely architecture of the ancestral type II
PKS gene cluster as KS, CLF, ACP, and TcmN and OxyN cyclases,
we traced the evolution of this ancestral cluster into characterized
extant clusters surviving today. We inferred key ancestors from
Fig. 2 and deduced functional consequences of the observed gene
swaps; the results are summarized in Fig. 4.
Resistomycin represents an important type II polyketide, because
its cluster is the most anciently diverged of the characterized set of
78. We studied all sequenced homologs of resistomycin to infer the
common ancestor (ancestor 2) of all 78 characterized systems (Fig.
4 and SI Appendix, Fig. S11). Few systems related to resistomycin
have been sequenced; many of the nearest relatives are from
metagenomic sequencing projects, including uncultivable bacteria.
Of the sequences that are available, the resistomycin-like architecture of KS-CLF, ACP, TcmN, OxyN, and TcmJ is conserved, suggesting that ancestor 2 gained a TcmJ cyclase. Interestingly, some
distant relatives of resistomycin harbor no ACP gene but retain the
three cyclases. Such anciently diverged gene clusters may represent
interesting targets for bioprospecting, given their unique sequence
and nonactinomycete origin.
The next key ancestor, which gave rise to the spore pigments and
all other systems (ancestor 3), underwent a swap of TcmI with

EVOLUTION

Gene

The apparent ancientness of the TcmN and OxyN cyclase genes
prompted us to investigate their evolutionary origins. It has been
shown that the 3D structure of TcmN cyclase bears similarity to the
“hot dog” fold of dehydratase proteins, which are often clustered
with PKS/FAS systems (27). Our own homology searches found
that OxyN-like cyclases share similarity and active site motifs with
formamidases and metal-dependent hydrolases (31). Both of these
protein classes are ancient, with homologs performing diverse
functions in diverse species. The type II PKS homologs comprise
only a small, recently evolved subset of each class (SI Appendix,
Figs. S12 and S13), suggesting that these cyclases were swapped
into the gene clusters from other systems and subsequently evolved
PKS-specific functions.

CHEMISTRY

Table 1. Number of gene clusters having at least one of the
listed accessory genes clustered within 30 kb of KS-CLF genes

Fig. 3. Coevolution of type II PKS KS with partner genes. (A) Schematic illustrating two nucleotide records and the clustered (within 30 kb) KS + partner on
each record. (B) KS1-KS2 pairwise amino acid identities are plotted vs. pairwise
identities of a clustered partner. (C–I) Correlation of evolutionary histories of
the KS with partner genes.
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OxyN (Figs. 2 and 4), both of which are thought to catalyze late ring
cyclization events. The TcmI and OxyN cyclase genes are observed
together in none of the 544 putative clusters (SI Appendix, Fig. S14),
so these genes may be mutually exclusive. Interestingly, OxyN reappears in one of the C20 subclades (Fig. 2), corresponding to a loss
in TcmI (ancestors 7 and 8). This gene swap appears correlated with
changes to polyketide ring topologies, because those C20 PKSs that
use OxyN produce molecules with linear topology, whereas those
C20 PKSs that use TcmI display a kink in the polyaromatic backbone (Fig. 4 and SI Appendix, Table S3).
Further diversification of type II PKS gene clusters occurred
upon the introduction of KR genes (Fig. 4). We observe that the
C19 KR was introduced into the ancestor of frankiamycin (32)
and all other characterized clusters (ancestor 4).
One of the most striking findings of the cluster-wide phylogenetic analysis is that all C16- to C21-encoding gene clusters
arose from a single common ancestor (ancestor 7). This ancestor
was likely C20, because there are nonmonophyletic clades of C20
systems descending from it (Fig. 2). This C20 ancestor proliferated rapidly and gave rise to the majority of characterized
type II polyketide antibiotics known today (e.g., tetracyclines)
(Figs. 1, 2, and 4). Ancestor 7 underwent a major, coordinated set
of mutations and gene swaps. We established above that the cavity
volume of these systems is significantly smaller than the cavity
volume of the C24–C30 systems (SI Appendix, Table S2). The gene
architectures are also significantly different. The more anciently
diverged, longer-chain systems harbor a monomeric TcmN gene,
whereas the more recently diverged CLFs encoding shorter chain
lengths (C16–C21) harbor a dimeric form of the gene (e.g., oxytetracycline otcD1). We hypothesized that the ancestral TcmN
monomer had duplicated to become the OtcD1-like dimer, but,

surprisingly, phylogenetic analysis of TcmN homologs refuted this
hypothesis; rather, the dimer and the monomer diverged before type
II PKSs proliferated in Actinobacteria, and the sequence-divergent
dimeric homolog (OtcD1-like) was swapped into the C16–C21
common ancestor (ancestor 7), replacing the monomeric TcmN-like
form (Figs. 3F and 4 and SI Appendix, Fig. S12).
An additional major change in key ancestor 7 was the replacement of a C19 KR with a C9 KR. Extensive biochemical analysis
and docking studies suggest that KR interactions with the minimal
PKS are essential during biosynthesis (33, 34), which could explain
why most clusters harbor either a C9 or C19 KR (although there are
exceptions, such as resistomycin, the spore pigments, and anciently
diverged orphans that harbor no KR). The C19- to C9-KR gene
swap events can be seen at the bottom of Fig. 3E, where KSs
of high sequence identity are clustered with KRs with low sequence identity. Finally, ancestor 7 lost a TcmJ homolog. Taken
together, these cluster-wide observations suggest that the transition from ancestor 6 to ancestor 7 involved the coordinated swaps
of cyclases (TcmN monomer with TcmN dimer and loss of TcmJ)
and KRs (C19 with C9). This ancestor further diversified via the
introduction of additional KRs (C15 and C17) and cyclase gene
swaps (TcmI to OxyN) to yield the diverse extant clusters seen
today (Figs. 2 and 4).
The functional consequences of key evolutionary events (Fig. 4)
can be predicted based on the known biochemistries of PKS
enzymes (SI Appendix, Fig. S1). The product of the original,
ancestral type II PKS gene cluster (ancestor 1 on Fig. 4) was
likely an acetyl-primed C20–C24 polyketide cyclized at the C9–
C14 position, because TcmN-like cyclases almost always facilitate C9–C14 cyclization events in the absence of a C9 KR
(95% of pathways; SI Appendix, Table S4). The introduction of

Fig. 4. Evolution of type II PKS gene clusters by coordinated gene swaps. The tree traces the key ancestors from the most anciently diverged type II PKS gene
clusters (Top) to the more recently diverged C20 systems, such as oxytetracycline and landomycin (Bottom). Highlighted in red are key ancestors, whose gene cluster
architecture is inferred on the left. Representative polyketide structures from each clade are shown, and activity sites for KR (gold), TcmN cyclase (green), and KSIII (light
blue) are shown on the chemical structures.

13956 | www.pnas.org/cgi/doi/10.1073/pnas.1511688112

Hillenmeyer et al.

1. Fischbach MA, Walsh CT, Clardy J (2008) The evolution of gene collectives: How natural
selection drives chemical innovation. Proc Natl Acad Sci USA 105(12):4601–4608.
2. Medema MH, et al. (2011) antiSMASH: Rapid identification, annotation and analysis
of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome
sequences. Nucleic Acids Res 39(Web Server issue):W339–W346.
3. Jenke-Kodama H, Börner T, Dittmann E (2006) Natural biocombinatorics in the polyketide synthase genes of the actinobacterium Streptomyces avermitilis. PLOS Comput Biol
2(10):e132.
4. Jenke-Kodama H, Sandmann A, Müller R, Dittmann E (2005) Evolutionary implications
of bacterial polyketide synthases. Mol Biol Evol 22(10):2027–2039.
5. Hertweck C (2009) The biosynthetic logic of polyketide diversity. Angew Chem Int Ed
Engl 48(26):4688–4716.
6. Hertweck C, Luzhetskyy A, Rebets Y, Bechthold A (2007) Type II polyketide synthases:
Gaining a deeper insight into enzymatic teamwork. Nat Prod Rep 24(1):162–190.
7. Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325(5944):
1089–1093.
8. Ridley CP, Lee HY, Khosla C (2008) Evolution of polyketide synthases in bacteria. Proc
Natl Acad Sci USA 105(12):4595–4600.
9. Tang Y, Tsai S-C, Khosla C (2003) Polyketide chain length control by chain length
factor. J Am Chem Soc 125(42):12708–12709.
10. Keatinge-Clay AT, Maltby DA, Medzihradszky KF, Khosla C, Stroud RM (2004) An
antibiotic factory caught in action. Nat Struct Mol Biol 11(9):888–893.
11. Nicholson TP, et al. (2003) First in vitro directed biosynthesis of new compounds by a
minimal type II polyketide synthase: Evidence for the mechanism of chain length
determination. Chem Commun (Camb) (6):686–687.
12. Szu P-H, et al. (2011) Analysis of the ketosynthase-chain length factor heterodimer
from the fredericamycin polyketide synthase. Chem Biol 18(8):1021–1031.
13. Yadav G, Gokhale RS, Mohanty D (2009) Towards prediction of metabolic products of
polyketide synthases: An in silico analysis. PLOS Comput Biol 5(4):e1000351.
14. Dreier J, Khosla C (2000) Mechanistic analysis of a type II polyketide synthase. Role
of conserved residues in the β-ketoacyl synthase-chain length factor heterodimer.
Biochemistry 39(8):2088–2095.
15. Burson KK, Khosla C (2000) Dissecting the chain length specificity in bacterial aromatic polyketide synthases using chimeric genes. Tetrahedron 56(48):9401–9408.
16. Höfle G, Kunze B (2008) Biosynthesis of aurachins A-L in Stigmatella aurantiaca:
A feeding study. J Nat Prod 71(11):1843–1849.
17. Pistorius D, Li Y, Sandmann A, Müller R (2011) Completing the puzzle of aurachin
biosynthesis in Stigmatella aurantiaca Sg a15. Mol Biosyst 7(12):3308–3315.
18. Cimermancic P, et al. (2014) Insights into secondary metabolism from a global analysis
of prokaryotic biosynthetic gene clusters. Cell 158(2):412–421.
19. Cohen O, Ashkenazy H, Burstein D, Pupko T (2012) Uncovering the co-evolutionary
network among prokaryotic genes. Bioinformatics 28(18):i389–i394.
20. Scornavacca C, Zickmann F, Huson DH (2011) Tanglegrams for rooted phylogenetic
trees and networks. Bioinformatics 27(13):i248–i256.
21. Summers RG, Ali A, Shen B, Wessel WA, Hutchinson CR (1995) Malonyl-coenzyme A:
acyl carrier protein acyltransferase of Streptomyces glaucescens: A possible link between fatty acid and polyketide biosynthesis. Biochemistry 34(29):9389–9402.

Hillenmeyer et al.

Methods
Materials and methods, along with supporting figures and a complete reference set of the 78 characterized type II polyketides, are provided in SI
Appendix.
ACKNOWLEDGMENTS. We thank Colin Harvey, Yi Tang, Marnix Medema, and
Raeka Aiyar for helpful discussions. We acknowledge support from Haverford
College (L.K.C. and E.E.B.), the Research Corporation for Science Advancement
Cottrell College Scholars Award (to L.K.C.), the Burroughs Wellcome Fund
Career Award at the Scientific Interface and NIH Grant U01 GM110706 (to
M.E.H.), and the Stanford School of Medicine Dean’s Office (G.A.V.).

22. Arthur CJ, et al. (2006) The malonyl transferase activity of type II polyketide synthase
acyl carrier proteins. Chem Biol 13(6):587–596.
23. Moore BS, Hertweck C (2002) Biosynthesis and attachment of novel bacterial polyketide synthase starter units. Nat Prod Rep 19(1):70–99.
24. Lackner G, et al. (2007) Biosynthesis of pentangular polyphenols: Deductions from the
benastatin and griseorhodin pathways. J Am Chem Soc 129(30):9306–9312.
25. Fritzsche K, Ishida K, Hertweck C (2008) Orchestration of discoid polyketide cyclization in the resistomycin pathway. J Am Chem Soc 130(26):8307–8316.
26. Jakobi K, Hertweck C (2004) A gene cluster encoding resistomycin biosynthesis in
Streptomyces resistomycificus; exploring polyketide cyclization beyond linear and
angucyclic patterns. J Am Chem Soc 126(8):2298–2299.
27. Ames BD, et al. (2008) Crystal structure and functional analysis of tetracenomycin
ARO/CYC: Implications for cyclization specificity of aromatic polyketides. Proc Natl
Acad Sci USA 105(14):5349–5354.
28. Shen B, Hutchinson CR (1996) Deciphering the mechanism for the assembly of aromatic polyketides by a bacterial polyketide synthase. Proc Natl Acad Sci USA 93(13):
6600–6604.
29. Thompson TB, Katayama K, Watanabe K, Hutchinson CR, Rayment I (2004) Structural
and functional analysis of tetracenomycin F2 cyclase from Streptomyces glaucescens.
A type II polyketide cyclase. J Biol Chem 279(36):37956–37963.
30. Pickens LB, Tang Y (2010) Oxytetracycline biosynthesis. J Biol Chem 285(36):
27509–27515.
31. Díaz-Sáez L, Srikannathasan V, Zoltner M, Hunter WN (2014) Structures of bacterial
kynurenine formamidase reveal a crowded binuclear zinc catalytic site primed to
generate a potent nucleophile. Biochem J 462(3):581–589.
32. Ogasawara Y, Yackley BJ, Greenberg JA, Rogelj S, Melançon CE, 3rd (2015) Expanding
our understanding of sequence-function relationships of type II polyketide biosynthetic gene clusters: Bioinformatics-guided identification of Frankiamicin A from
Frankia sp. EAN1pec. PLOS One 10(4):e0121505.
33. Hertweck C, et al. (2004) Context-dependent behavior of the enterocin iterative
polyketide synthase; a new model for ketoreduction. Chem Biol 11(4):461–468.
34. Javidpour P, et al. (2013) The determinants of activity and specificity in actinorhodin
type II polyketide ketoreductase. Chem Biol 20(10):1225–1234.
35. Korman TP, Tan Y-H, Wong J, Luo R, Tsai S-C (2008) Inhibition kinetics and emodin cocrystal
structure of a type II polyketide ketoreductase. Biochemistry 47(7):1837–1847.
36. Poust S, Hagen A, Katz L, Keasling JD (2014) Narrowing the gap between the promise
and reality of polyketide synthases as a synthetic biology platform. Curr Opin
Biotechnol 30:32–39.
37. O’Brien RV, Davis RW, Khosla C, Hillenmeyer ME (2014) Computational identification and
analysis of orphan assembly-line polyketide synthases. J Antibiot (Tokyo) 67(1):89–97.
38. Bachmann BO, Van Lanen SG, Baltz RH (2014) Microbial genome mining for
accelerated natural products discovery: Is a renaissance in the making? J Ind Microbiol
Biotechnol 41(2):175–184.
39. Ma J, et al. (2006) Reconstructing contiguous regions of an ancestral genome.
Genome Res 16(12):1557–1565.
40. Gaucher EA, Govindarajan S, Ganesh OK (2008) Palaeotemperature trend for Precambrian life inferred from resurrected proteins. Nature 451(7179):704–707.

PNAS | November 10, 2015 | vol. 112 | no. 45 | 13957

EVOLUTION

Conclusions
Type II PKSs are responsible for the biosynthesis of pharmacologically relevant natural products, and discovery and engineering of
new polyketides are of great interest. Investigating the evolution of
entire microbial gene clusters, as opposed to individual genes, is a
nascent field that has become possible only recently with the large
number of microbial genomes being sequenced. We tackled the
question of how type II PKS gene clusters evolved by studying the
evolution of the KS-CLF and its coevolution with accessory genes.
Remarkably, divergence of the PKS KS (and CLF) from the FabF
KS apparently occurred before bacterial speciation. Chemical innovation was driven by mutations in the KS-CLF gene pair to accommodate polyketides of variable length and changes to the
accessory gene roster to diversify the oxidation state, priming unit,
and cyclization patterns of the natural product.
The methods presented here for studying the evolution of type II
PKSs are generalizable and can be applied to other biosynthetic

systems, where gene swaps may also be a source of chemical diversity. In addition to reconstructing the evolutionary history of an
important class of natural products, these results represent a
launching point for bioprospecting in three ways. First, the lessons
learned about nature’s strategies to generate chemical diversity may
guide rational design and engineering of hybrid synthases (36). Our
study reveals patterns in gene compatibility that can be used as
ground rules for engineering. Second, we identified orphan gene
clusters from diverse phyla that may encode novel chemical structures that could potentially be expressed in tractable nonactinobacterial hosts (18, 37, 38). Finally, ancestral sequence reconstruction,
which has been applied to single proteins and whole genomes (39,
40), could be applied to ancestral gene clusters, leading to a potentially novel source of chemical diversity: the resurrection of extinct gene clusters and chemicals.

CHEMISTRY

the C19 KR in ancestor 4 likely changed the oxidation state of
the polyaromatic core. The gene swap of C9 for C19 likely
changed both the oxidation state and the cyclization pattern,
because in the presence of a C9 KR, the TcmN-like cyclase catalyzes C7–C12 ring closure (5, 10, 25, 35). The swap of TcmI for
OxyN in ancestor 8 is correlated with a change in the polyketide
structure from bent to linear. The global chemical innovation
was likely driven by a combination of these key gene swap events
with mutations to the KS-CLF core.

